Michael K. Handley serves as Executive at Cytocom, Inc., where they oversee executive responsibilities. Since joining the company, Michael K. Handley has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jul 27, 2021 involved receiving (via award) 296,609 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Jul 27, 2021 | CBLI | $0 | Award | 296,609 | $N/A | Discretionary |
Michael K. Handley currently holds 296,609 shares of Cytocom, Inc. (CBLI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Michael K. Handley has been a net neutral trader of CBLI stock. They have purchased $0 and sold $0 worth of shares.
Michael K. Handley's most recent insider trade was on Jul 27, 2021, when they sold 296,609 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted